In this video, Ben Lockshin, MD, shares his perspective on the evolving role of oral therapies in psoriasis care. He highlights how a once-daily oral option offers strong efficacy, durability, and safety, while also meeting patient demand for alternatives to injections. With practical insights on tolerability, monitoring, and long-term outcomes, Dr Lockshin explains why oral therapy is becoming an important first-line consideration for patients eligible for systemic treatment.